Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.79 |
| ▸ | GFER | P55789 | 1/20 | 0.79 |
| ▸ | NGLY1 | Q96IV0 | 1/20 | 0.79 |
| ▸ | FABP4 | P15090 | 1/20 | 0.66 |
| ▸ | AKR1C3 | P42330 | 10/20 | 0.64 |
| ▸ | AKR1C2 | P52895 | 10/20 | 0.64 |
| ▸ | CTSV | O60911 | 2/20 | 0.60 |
| ▸ | CTSL | P07711 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.50 |
| ▸ | TAS2R14 | Q9NYV8 | 1/20 | 0.50 |
| ▸ | DHODH | Q02127 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9172301 | 0.98 | MAPT (0.76) | MAPTGFERNGLY1FABP4AKR1C3 | |
| Hydrochloric Acid SCHEMBL28298843 | 0.92 | MAPT (0.73) | MAPTGFERNGLY1FABP4AKR1C3 | |
| SCHEMBL8833788 | 0.91 | MAPT (0.67) | MAPTGFERNGLY1FABP4AKR1C3 | |
| SCHEMBL8002116 | 0.91 | MAPT (0.67) | MAPTGFERNGLY1FABP4AKR1C3 | |
| SCHEMBL708364 | 0.89 | MAPT (0.65) | MAPTGFERNGLY1FABP4AKR1C3 | |
| SCHEMBL11647944 | 0.89 | MAPT (0.65) | MAPTGFERNGLY1FABP4AKR1C3 | |
| SCHEMBL14598924 | 0.89 | MAPT (0.65) | MAPTGFERNGLY1FABP4AKR1C3 | |
| SCHEMBL14349651 | 0.89 | GFER (0.65) | MAPTGFERNGLY1FABP4AKR1C3 | |
| SCHEMBL3234696 | 0.89 | MAPT (0.65) | MAPTGFERNGLY1FABP4AKR1C3 | |
| SCHEMBL13271182 | 0.89 | MAPT (0.65) | MAPTGFERNGLY1FABP4AKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 868 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| WO-2025238576-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | Nuovo Pignone Tecnologie – S.r.l. (IT) | 2025-11-20 | — | — | WO | claimed |
| US-20250354659-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | NUOVO PIGNONE TECNOLOGIE – S R L (IT) | 2025-11-20 | — | — | US | claimed |
| CN-117720824-B | Improved method for manufacturing quinacridone solid solution pigment | 温州金源新材料科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| EP-4556112-A2 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-05-21 | — | — | EP | claimed |
| CN-119869460-A | Sorbent compositions, systems, and methods | 通用电气技术有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-12263464-B2 | Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2025-04-01 | — | — | US | claimed |
| CN-119463525-A | Preparation method of quinacridone pigment | 宇虹颜料股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119060559-A | Beta-quinacridone organic pigment and preparation method thereof | 绍兴上虞新利化工有限公司 | 2024-12-03 | — | — | CN | claimed |
| WO-1992009558-A1 | METHOD OF PREPARING 2,5-DI(PHENYLAMINO)TEREPHTHALIC ACID AND ITS DIALKYL ESTERS AS HIGH-PURITY PRODUCTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-06-11 | — | — | WO | claimed |
| US-4956464-A | Cyclization, dehydrogenation in the vapor phase or solid phase in the presence of an oxidizer | BASF AKTIENGESELLSCHAFT (DE) | 1990-09-11 | — | — | US | claimed |
| US-4758665-A | Process for preparing high-hiding gamma-modification of unsubstituted linear transquinacridone | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-07-19 | — | — | US | claimed |
| EP-0142066-B1 | COVERING GAMMA MODIFICATION OF A NON SUBSTITUTED LINEAR TRANS-QUINACRIDONE | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-11-25 | — | — | EP | claimed |
| EP-0142066-A2 | Covering gamma modification of a non substituted linear trans-quinacridone | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-05-22 | — | — | EP | claimed |
| EP-0001613-B1 | PROCESS FOR PREPARING LINEAR TRANS-QUINACRIDONE IN GAMMA-CRYSTAL MODIFICATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1982-09-29 | — | — | EP | claimed |
| US-4212975-A | Process for the manufacture of the gamma-crystal modification of linear trans-quinacridone | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-07-15 | — | — | US | claimed |
| EP-0001613-A1 | Process for preparing linear trans-quinacridone in gamma-crystal modification | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-05-02 | — | — | EP | claimed |
| US-4100162-A | Process for preparing gamma quinacridone from polyphosphoric acid and alcohol | HARMON COLORS (US) | 1978-07-11 | — | — | US | claimed |
| US-4064129-A | Process for making quinacridone and its derivatives | HARMON COLORS CORPORATION (US) | 1977-12-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | MAPT 1454/4885GFER 355/4885NGLY1 3273/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.